Immunmodulierende therapie der multiplen sklerose mit betainterferon

B. Bereznai, R. Hohlfeld

Research output: Review article

1 Citation (Scopus)


Treatment for multiple sclerosis has changed considerably in the last few years. Four multicentre, double-blind, placebo-controlled studies have resulted in licenses being issued for a number of preparations. The present summary discusses the study results and clinical aspects of beta interferon therapy.

Translated title of the contributionImmunomodulatory treatment of multiple sclerosis with betainterferon
Original languageGerman
Pages (from-to)115-117
Number of pages3
JournalMunchener Medizinische Wochenschrift
Issue number10
Publication statusPublished - márc. 12 1999

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunmodulierende therapie der multiplen sklerose mit betainterferon'. Together they form a unique fingerprint.

  • Cite this